Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR... ( CAMBRIDGE Mass. Oct. 22 /- Millen...)

Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium

Date:10/22/2008

CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced new data from early non-clinical studies of Millennium/Takeda-discovered pipeline molecules highlighting novel therapeutic pathways in oncology. MLN4924 data build on the growing body of evidence supporting the importance of the Millennium-discovered Nedd8 Activating Enzyme (NAE) in tumor growth and survival. It is a first-in-class small molecule inhibitor of NAE. Both clinical and non-clinical studies of MLN8237 confirm the importance of inhibiting Aurora A kinase, which is required for cells to proceed through cell division.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080827/NEW076LOGO )

TAK-285 and TAK-593 are receptor tyrosine kinase inhibitors. Non-clinical data suggest their efficacy in affecting the Epidermal Growth Factor Receptor / Human Epidermal Growth Factor Receptor (EGFR/HER) and Vascular Endothelial Growth Factor/Platelet Derived Growth Factor (VEGF/PDGF) pathways, respectively. The data from 21 Millennium abstracts were presented at the 20th EORTC-NCI-AACR* Symposium on "Molecular Targets and Cancer Therapeutics" held October 21 to 24 in Geneva, Switzerland.

"These new data demonstrate the potential of novel pathways and innovative approaches to existing pathways that will further oncology research," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "Early results such as these demonstrate our oncology expertise in advancing both the current Millennium oncology molecules and those we are integrating into our pipeline from Takeda."

MLN4924

MLN4924 is a first-in-class small molecule inhibitor of NAE, a new target discovered by Millennium scientists. Data from two non-clinical studies showcased at EORTC highlight its potent activity in inducing apoptosis, or programmed cell death, in cultured human tumor cells and human
'/>"/>

SOURCE Millennium: The Takeda Oncology Company
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
2. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
5. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
6. Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
7. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
8. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
9. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
10. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
11. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America

Post Your Comments:

(Date:5/22/2013)... Jersey , 22. Mai 2013 /PRNewswire/ ... Fähigkeitsentwicklung und Beratung, gab heute bekannt, dass ... Chris Geraghty , zum Hauptgeschäftsführer ernannt ... Jahre im Industriebereich wo er zahlreiche Führungspositionen ... von Ray Baxter an, der als Kepner-Tregoe ...

(Date:5/22/2013)... 2013 Z-Medica, a leading developer and marketer ... first-ever line of products designed to meet the unique ... ® EMS 4x4 Dressing, QuikClot ® EMS ... Gauze™, all custom-designed to help responders stop bleeding fast ... to a hospital or trauma center. The line includes ...

(Date:5/22/2013)... -- MGT Capital Investments, Inc. (NYSE MKT: MGT) announced today ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... the Grand Hyatt Hotel. Robert Ladd ... and answer questions. (Logo: http://photos.prnewswire.com/prnh/20130409/NY91046LOGO ... begin at 9:30 a.m. EDT. MGT,s latest presentation materials ...

Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2 Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3 Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4

[0] Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer [0] Z-Medica Launches New Line of Hemostatic Agents for use in Emergency Medical Services [0] MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference

... University of Bari, Italy, concluded that treating patients after ... (SVR) and protects them from liver-related deaths. The purpose ... outcomes of patients posttransplant who underwent antiviral therapy for ... graft. The use in clinical practice ...

... SPRING, Md., Oct. 29 The U.S. Food ... an injectable antibiotic to treat adults with community ... and skin structure infections (ABSSSI), including methicillin-resistant ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ...

Cached Medicine Technology:Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes 2 FDA Approves Teflaro for Bacterial Infections 2 FDA Approves Teflaro for Bacterial Infections 3

Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes FDA Approves Teflaro for Bacterial Infections

(Date:5/22/2013)... (PRWEB) May 22, 2013 On May 16, ... or more on average, a funeral concierge can help families ... other benefits. Funeral Financials announces their top ... household income in the U.S. having dropped 7.3 ... Sentier Research, the average funeral costs 12.6% of an average ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 TWITTER: @the_USO ... Family Tour together, heading to 8 countries in the next 6 ... Street, Cookie Monster and Members of Congress came together to show ... assembled 2,000 USO Care Packages for distribution to our ... celebrate the five-year partnership of Sesame Street and the USO as ...

(Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...

(Date:5/22/2013)... May 22, 2013 Successful Therapy ... Patricia O’Laughlin Psychotherapy in the Silver Lake community ... all ages as progression to existing Parents and ... ages into parenting therapy has always been suggested, ... O’Laughlin Psychotherapy now specializes in all aspects of ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...

[0] Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge [0] The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC [0] Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners [0] Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort

... WHAT: The community is invited to attend a ... of Momentum in Science, part of a four-part documentary, ... Thursday, May 7 ... distinguished panel of local, internationally renowned, ...

... Attorney A. Brian Albritton announces the filing of ... concerning WellCare Health Plans, Inc. (WellCare). The Information ... employees, in an elaborate scheme to defraud the ... Corporation ("Healthy Kids" or FHKC) program of approximately ...

... and commitment to education about this rare disease -- ... on Monday, May 11, 2009 at the Mondrian Hotel ... with National Eosinophil Awareness Week, the American Partnership for ... and the Jonas Group,s Ned Specktor as 2009-2010 Honorary ...

... Calif., May 5 As of May 5, 2009, ... of Influenza A (H1N1) infection in 21 different countries. ... virus continues to evolve, the Centers for Disease Control ... Interim Guidance on Specimen Collection and Processing for Patients ...

... HOME, Ark., May 5 Baxter Regional Medical Center ... patient satisfaction , in the National ... Emergency Department. They have also reached number one in ... in Missouri. Compirion Healthcare Solutions, a hospital process improvement ...

... Antioxidant-Rich Spices and Herbs Can Enhance Your Daily Routine ... is here, motivating many people to eat more healthfully ... overhaul and change in routine can seem overwhelming. That,s ... focus to small, achievable steps is a concept that,s ...

Cached Medicine News:Health News:HBO, the Arizona Alzheimer's Consortium and the Alzheimer's Association, Desert Southwest Chapter Present a Free Advance Screening of THE ALZHEIMER'S PROJECT: Momentum In Science 2 Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 2 Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 3 Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 4 Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 5 Health News:The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education 2 Health News:The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education 3 Health News:CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus 2 Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 2 Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 3 Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 4 Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 5 Health News:Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally 6 Health News:Simple Steps Toward a Healthy Lifestyle 2 Health News:Simple Steps Toward a Healthy Lifestyle 3

HBO, the Arizona Alzheimer's Consortium and the Alzheimer's Association, Desert Southwest Chapter Present a Free Advance Screening of THE ALZHEIMER'S PROJECT: Momentum In Science Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Group's Ned Specktor, as 2009-2010 Honorary Ambassadors of Education CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus Compirion Helps Baxter Regional Medical Center Achieve Patient Satisfaction Rankings in the Top 5th Percentile Nationally Simple Steps Toward a Healthy Lifestyle

Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....

Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....

Used to introduce balloon, electrode, closed or non-tapered end and other catheters....

Sheath Introducer featuring patented SLIX Valve, rotating collar, kink-resistant cannula and atraumatic tip transitions....

Medicine Products:

FLEXOR CHECK-FLO Introducer Set Large Valve Assembly with Radiopaque Band CHECK-FLO Performer Introducers CHILDRENS HOSPITAL BOSTON MODIFICATION CHECK-FLO PERFORMER INTRODUCER SETS Avanti+ Catheter Sheath Introducer